Title : A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone.

Pub. Date : 2002 Jun

PMID : 12080288






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. Naltrexone interleukin 2 Homo sapiens